MediPharm Labs, a contract and development and manufacturing company, brings a pharmaceutical perspective to the cannabis industry; working to internationally recognized pharma-quality standards, our cannabis products that are PURE, TRUSTED and PRECISELY DOSABLE for patients and end consumers. MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates for derivative products in Canada and Australia. It also provides cannabis contract processing services to licensed producers and growers; and tolling services to licensed cultivators in Canada. In addition, the company supplies purified cannabis concentrate raw materials and product formulations for ready-to-sell advanced cannabis products. Further, it engages in the real estate business. The company was founded in 2015 and is headquartered in Barrie, Canada.